Anaesthetic management of an infant with MEGD(H)EL syndrome undergoing cochlear implant

Nashwa Ahmed
DOI: https://doi.org/10.1186/s12871-024-02812-2
IF: 2.376
2024-11-28
BMC Anesthesiology
Abstract:The syndrome has these features: 3-methylglutaconic aciduria (MEG), deafness(D), encephalopathy (E), Leigh-like syndrome (L). This disorder is caused by biallelic mutations in serine active site-containing protein 1 (SERAC1) gene. When these patients experience hepatopathy (H) in addition to the above manifestations, the syndrome is referred to as MEGD(H)EL. The pathology of this syndrome shares features with diverse types of inborn errors of metabolism.
anesthesiology
What problem does this paper attempt to address?